UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Keeping Patients on Treatment: Management of Toxicities Related to New Therapies and Challenges of Symptom Management Research

Clinical lymphoma, myeloma and leukemia, 2015-09, Vol.15, p.e315-e315

Faiman, B

2015

Volltextzugriff (PDF)

Nothing means anything if everything means something: exploring the issues of coping profiles and the person-centered approach

Anxiety, stress, and coping, 2024-07, p.1-22

2024

Volltextzugriff (PDF)

Lenalidomide and pegylated liposomal doxorubicin-based chemotherapy for relapsed or refractory multiple myeloma: safety and efficacy

Annals of oncology, 2006-12, Vol.17 (12), p.1766-1771

2006

Volltextzugriff (PDF)

A Pilot Placebo Controlled Study to Estimate the Effect Size of Glutamine to Prevent Peripheral Neuropathy in Multiple Myeloma

Clinical lymphoma, myeloma and leukemia, 2015-09, Vol.15, p.e318-e318

2015

Volltextzugriff (PDF)

Symptom Management and Adherence in Multiple Myeloma (MM): A Plan to Disseminate Best- Practice Guidelines for Nurses

Clinical lymphoma, myeloma and leukemia, 2017-02, Vol.17 (1), p.e160-e160

2017

Volltextzugriff (PDF)

Lack of Health Maintenance Exams and Risk: An Internet-Based Survey on Health Maintenance and Preventive Care Patterns in Patients with Myeloma

Clinical lymphoma, myeloma and leukemia, 2015-09, Vol.15, p.e317-e317

2015

Volltextzugriff (PDF)

The Role of Aspirin in the Prevention of Thrombotic Complications of Thalidomide and Anthracycline-Based Chemotherapy for Multiple Myeloma

Mayo Clinic proceedings, 2005-12, Vol.80 (12), p.1568-1574

2005

Volltextzugriff (PDF)

Patient, Care Partner, and Physician Voices in Treatment Decision-Making for Multiple Myeloma

Patient preference and adherence, 2024-01, Vol.18, p.2147-2158

2024

Volltextzugriff (PDF)

Assessment and monitoring of patients receiving chemotherapy for multiple myeloma: strategies to improve outcomes

Blood and lymphatic cancer, 2016-01, Vol.6 (Issue 1), p.21-35

2016

Volltextzugriff (PDF)

Innovative agents in multiple myeloma

Journal of the advanced practitioner in oncology, 2014-05, Vol.5 (3), p.193-202

2014

Volltextzugriff (PDF)

PB2155 ONLINE CME SIGNIFICANTLY IMPACTS MULTIPLE MYELOMA CLINICIANS: EXPERIENCE FROM A MULTI‐YEAR CURRICULUM WITH 33,699 LEARNERS

HemaSphere, 2019-06, Vol.3 (S1), p.968-969

2019

Volltextzugriff (PDF)

The role of race, socioeconomic status, and distance traveled on the outcome of African-American patients with multiple myeloma

Haematologica (Roma), 2006-10, Vol.91 (10), p.1410-1413

2006

Volltextzugriff (PDF)

How Do We Achieve Value-Based, Patient-Centered Care?

Journal of the advanced practitioner in oncology, 2024-09, Vol.15 (6), p.340-341

Faiman, Beth

2024

Volltextzugriff (PDF)

Artificial Intelligence: How Is it Relevant to Advanced Practitioners?

Journal of the advanced practitioner in oncology, 2024-07, Vol.15 (5), p.293-294

Faiman, Beth

2024

Volltextzugriff (PDF)

Prediction of Response and Progression in Multiple Myeloma With Serum Free Light Chains Assay: Corroboration of the Serum Free Light Chain Response Definitions

Clinical lymphoma, myeloma and leukemia, 2010-02, Vol.10 (1), p.E10-E13

2010

Volltextzugriff (PDF)

High Altitude Help: Medical Emergencies in the Air

Journal of the advanced practitioner in oncology, 2024-05, Vol.15 (4), p.233-234

Faiman, Beth

2024

Volltextzugriff (PDF)

Shaping the Future of Oncology at JADPRO Live 2023

Journal of the advanced practitioner in oncology, 2024-04, Vol.15 (3), p.162-163

Faiman, Beth

2024

Volltextzugriff (PDF)

The Cost of Care: Financial and Social Factors in Cancer Management

Journal of the advanced practitioner in oncology, 2024-01, Vol.15 (1), p.13-14

Faiman, Beth

2024

Volltextzugriff (PDF)

JADPRO Live 2023: Shaping the Future of Oncology

Journal of the advanced practitioner in oncology, 2023-11, Vol.14 (7), p.569-570

Faiman, Beth

2023

Volltextzugriff (PDF)

The Importance of Endpoints in Oncology Clinical Trials

Journal of the advanced practitioner in oncology, 2023-09, Vol.14 (6), p.466-467

Faiman, Beth

2023

Volltextzugriff (PDF)

Phase II study of dexamethasone, ascorbic acid, thalidomide and arsenic trioxide (DATA) in high risk previously untreated (PU) and relapsed/refractory (RR) multiple myeloma (MM)

Journal of clinical oncology, 2006-06, Vol.24 (18_suppl), p.17535-17535

2006

Volltextzugriff (PDF)

Providing Care During Cancer Drug Shortages

Journal of the advanced practitioner in oncology, 2023-07, Vol.14 (5), p.356-357

Faiman, Beth

2023

Volltextzugriff (PDF)

Tips for Writing a Research Protocol

Journal of the advanced practitioner in oncology, 2023-05, Vol.14 (4), p.269-270

Faiman, Beth

2023

Volltextzugriff (PDF)

JADPRO Live 2022: Reaching the Peak of Practice

Journal of the advanced practitioner in oncology, 2023-04, Vol.14 (3), p.189-190

Faiman, Beth

2023

Volltextzugriff (PDF)

The Importance of Professional Communities and Collaborations

Journal of the advanced practitioner in oncology, 2023-03, Vol.14 (2), p.115-116

Faiman, Beth

2023

Volltextzugriff (PDF)

1 – 25 von 152

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(84)
Mit Volltextzugriff
(130)

Publikationsform

Sprache

Englisch
(150)
Russisch
(2)

Erscheinungsjahr

n.n

Thema

Science & Technology
(60)
Life Sciences & Biomedicine
(49)
Humans
(29)
Male
(25)
Female
(23)
Animals
(21)
Biological And Medical Sciences
(19)
Middle Aged
(15)
Adult
(14)
Aged
(14)
Medical Sciences
(14)
Physics
(11)
Oncology
(10)
Follicle Stimulating Hormone - Blood
(8)
Luteinizing Hormone - Blood
(8)
Multiple Myeloma
(8)
Physical Sciences
(8)
Rats
(8)
Technology
(8)
Endocrinology & Metabolism
(7)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Keeping Patients on Treatment: Management of Toxicities Related to New Therapies and Challenges of Symptom Management Research

Nothing means anything if everything means something: exploring the issues of coping profiles and the person-centered approach

Lenalidomide and pegylated liposomal doxorubicin-based chemotherapy for relapsed or refractory multiple myeloma: safety and efficacy

A Pilot Placebo Controlled Study to Estimate the Effect Size of Glutamine to Prevent Peripheral Neuropathy in Multiple Myeloma

Symptom Management and Adherence in Multiple Myeloma (MM): A Plan to Disseminate Best- Practice Guidelines for Nurses

Lack of Health Maintenance Exams and Risk: An Internet-Based Survey on Health Maintenance and Preventive Care Patterns in Patients with Myeloma

The Role of Aspirin in the Prevention of Thrombotic Complications of Thalidomide and Anthracycline-Based Chemotherapy for Multiple Myeloma

Patient, Care Partner, and Physician Voices in Treatment Decision-Making for Multiple Myeloma

Assessment and monitoring of patients receiving chemotherapy for multiple myeloma: strategies to improve outcomes

Innovative agents in multiple myeloma

PB2155 ONLINE CME SIGNIFICANTLY IMPACTS MULTIPLE MYELOMA CLINICIANS: EXPERIENCE FROM A MULTI‐YEAR CURRICULUM WITH 33,699 LEARNERS

The role of race, socioeconomic status, and distance traveled on the outcome of African-American patients with multiple myeloma

How Do We Achieve Value-Based, Patient-Centered Care?

Artificial Intelligence: How Is it Relevant to Advanced Practitioners?

Prediction of Response and Progression in Multiple Myeloma With Serum Free Light Chains Assay: Corroboration of the Serum Free Light Chain Response Definitions

High Altitude Help: Medical Emergencies in the Air

Shaping the Future of Oncology at JADPRO Live 2023

The Cost of Care: Financial and Social Factors in Cancer Management

JADPRO Live 2023: Shaping the Future of Oncology

The Importance of Endpoints in Oncology Clinical Trials

Phase II study of dexamethasone, ascorbic acid, thalidomide and arsenic trioxide (DATA) in high risk previously untreated (PU) and relapsed/refractory (RR) multiple myeloma (MM)

Providing Care During Cancer Drug Shortages

Tips for Writing a Research Protocol

JADPRO Live 2022: Reaching the Peak of Practice

The Importance of Professional Communities and Collaborations

Suchergebnisse filtern